News

A clinical trials has shown that patients with intermediate-risk breast cancer had similar rates of ten-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy. To evaluate the impact of post-mastectomy CWI in patients with intermediate-risk breast cancer, researchers conducted the BIG 2-04 MRC SUPREMO Phase 3 clinical trial. The international [...]

Lushi, a women-led start-up, has launched to offer treatments, clinics, and wellness platforms in order to help transform the IVF and egg freezing experience for women. Women can use Lushi to hire injection specialists to administer fertility shots, use remote monitoring to support them through the process. Women will also have access to ‘My Fertility [...]

Women's health company Daré Bioscience has announced that additional data from the exploratory Phase 2b RESPOND clinical study of Sildenafil Cream, an investigational topical cream formulation of sildenafil being developed as an on-demand treatment for female sexual arousal disorder (FSAD), has shown positive results. The exploratory Phase 2b RESPOND study was specifically designed to identify [...]

Birmingham Women’s Hospital is now home to the NHS’s first simulation suite dedicated to maternal and neonatal health  following a £1 m donation from high street fashion entrepreneur George Davies via the George Davies Charitable Trust.  The new simulation lab has improved the training of maternity and neonatal teams, offering the opportunity to learn and [...]

A first-of-its-kind collaboration of multibillion-dollar funds is coming together to launch the WHAM Investment Collaborative designed to accelerate innovation and unlock opportunities within the women’s health market. Despite women making up half of the global population and driving much of the economy, women-founded companies receive just 2 per cent of venture capital funding. The WHAM [...]

A novel ultrasound technology is being utilised to accurately measure and monitor breast density, and in the process improve early detection rates and assess how at risk individual women might be from developing the disease. Approximately 70 per cent of breast cancers are detected in women with dense breasts, however, most women do not know [...]

An integrated polygenic risk score (iPRS) for personalised breast cancer risk assessment has been launched which reports five-year and lifetime breast cancer risk, offers individuals who receive a negative test result. The risk assessment has been launched by cell-free DNA and genetic testing company Natera and clinical whole genome analysis and polygenic risk modelling company [...]

Femtech World showcases some of the most innovative and impactful menopause products, tools and services that could help you in the year ahead. Recent years have seen a surge in the range and volume of products aimed at addressing challenges associated with the menopause. This comes as more and more health and wellbeing innovators turn [...]

A study in women with breast cancer suggests that low oral doses of hair loss drug minoxidil, taken during or after cancer treatment, appear to regrow hair in most patients and without causing any serious heart-related side effects that require additional therapies or hospitalisation. Led by researchers at NYU Langone Health, the new analysis included [...]

A groundbreaking Phase 1 clinical trial has explored a novel cell-based immunotherapy for breast cancer - a new treatment approach that aims to harness the body’s immune system to enhance patient responses and reduce the need for conventional chemotherapy and its associated toxicities. The trial involved 12 patients with locally advanced stage I-III HER2 breast [...]